CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
94.18
-1.81 (-1.89%)
At close: May 19, 2026, 4:00 PM EDT
94.13
-0.05 (-0.05%)
After-hours: May 19, 2026, 7:59 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, CVS Health stock has a consensus rating of "Buy" and an average price target of $101.58. The average 1-year stock price forecast is 7.86% higher than the current stock price, while the lowest is $79 (-16.12%) and the highest is $140 (+48.65%).
Price Target: $101.58 (+7.86%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CVS Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 8 | 8 | 7 | 7 | 7 |
| Buy | 11 | 10 | 10 | 11 | 11 | 11 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 19 | 19 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $93 → $106 | Buy | Maintains | $93 → $106 | +12.55% | May 14, 2026 |
| Bernstein | Bernstein | Buy Maintains $94 → $106 | Buy | Maintains | $94 → $106 | +12.55% | May 13, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $101 → $111 | Buy | Maintains | $101 → $111 | +17.86% | May 12, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $105 → $110 | Strong Buy | Maintains | $105 → $110 | +16.80% | May 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $102 → $103 | Buy | Maintains | $102 → $103 | +9.37% | May 8, 2026 |
Financial Forecast
Revenue This Year
413.21B
from 399.83B
Increased by 3.34%
Revenue Next Year
431.20B
from 413.21B
Increased by 4.35%
EPS This Year
7.51
from 1.39
Increased by 440.24%
EPS Next Year
8.46
from 7.51
Increased by 12.71%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 447.0B | 468.3B | ||||||
| Avg | 413.2B | 431.2B | ||||||
| Low | 397.2B | 407.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 11.8% | 13.3% | ||||||
| Avg | 3.3% | 4.4% | ||||||
| Low | -0.7% | -1.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 8.03 | 8.96 | ||||||
| Avg | 7.51 | 8.46 | ||||||
| Low | 7.22 | 7.98 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 477.9% | 19.3% | ||||||
| Avg | 440.2% | 12.7% | ||||||
| Low | 419.6% | 6.2% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.